His lab is focusing on refining the alanine-scanning assay to a few important residues which can accurately distinguish between fibrils from neurodegenerative tauopathies. He envisions applying this streamlined assay for postmortem neuropathological prognosis, and possibly for blood screening of tauopathies.Immerse yourself in TAU’s Daring and em